Regulation of utrophin in transgenic mice (multiple letters)

Regulation of utrophin in transgenic mice (multiple letters)

Opis bibliograficzny
Główni autorzy:	Davies, K, Stocksley, M, Chakkalakal, J, Bradford, A, Miura, P, De Repentigny, Y, Kothary, R, Jasmin, B
Format:	Journal article
Język:	English
Wydane:	2005

Podobne zapisy

Regulation of utrophin in transgenic mice.
od: Davies, K
Wydane: (2005)

Utrophin up-regulation by an artificial transcription factor in transgenic mice
od: Mattei, E, i wsp.
Wydane: (2007)

Utrophin up-regulation by an artificial transcription factor in transgenic mice.
od: Elisabetta Mattei, i wsp.
Wydane: (2007-08-01)

Prevention of pathology in mdx mice by expression of utrophin: analysis using an inducible transgenic expression system.
od: Squire, S, i wsp.
Wydane: (2002)

A and B utrophin in human muscle and sarcolemmal A-utrophin associated with tumours.
od: Sewry, C, i wsp.
Wydane: (2005)

Immunogold confirmation that utrophin is localized to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle.
od: Culle, M, i wsp.
Wydane: (2001)

Generation of clusters of dystrophin revertant fibers requires muscle regeneration and tests the function of dystrophin/utrophin transgenes
od: Yokota, T, i wsp.
Wydane: (2004)

Understanding the endothelial function of utrophin.
od: Ehmsen, J, i wsp.
Wydane: (2002)

Utrophin luciferase knock-in mouse model for in vivo assessment of drug efficacy in preclinical trials for utrophin upregulation
od: Fairclough, R, i wsp.
Wydane: (2010)

Confirmation by immunogold labeling that utrophin is localised to the normal position of dystrophin in dystrophin-negative transgenic mouse muscle
od: Cullen, M, i wsp.
Wydane: (2001)

Up-regulation of utrophin alleviates the dystrophic phenotype in the mdx mouse heart
od: Sang, E, i wsp.
Wydane: (2000)

Utrophin upregulation in Duchenne muscular dystrophy.
od: Hirst, R, i wsp.
Wydane: (2005)

A-utrophin up-regulation in mdx skeletal muscle is independent of regeneration.
od: Weir, A, i wsp.
Wydane: (2004)

Translational regulation of utrophin by miRNAs.
od: Utpal Basu, i wsp.
Wydane: (2011-01-01)

Utrophin in the therapy of Duchenne Muscular Dystrophy
od: Potter, A, i wsp.
Wydane: (2006)

Prevention of the dystrophic phenotype in dystrophin/utrophin-deficient muscle following adenovirus-mediated transfer of a utrophin minigene.
od: Wakefield, P, i wsp.
Wydane: (2000)

Muscle structure influences utrophin expression in mdx mice.
od: Glen B Banks, i wsp.
Wydane: (2014-06-01)

IRES-mediated translation of utrophin A is enhanced by glucocorticoid treatment in skeletal muscle cells.
od: Pedro Miura, i wsp.
Wydane: (2008-01-01)

Microarray analysis of mdx mice expressing high levels of utrophin: therapeutic implications for dystrophin deficiency.
od: Baban, D, i wsp.
Wydane: (2008)

The role of utrophin in the potential therapy of Duchenne muscular dystrophy.
od: Perkins, K, i wsp.
Wydane: (2002)

Functional substitution by TAT-utrophin in dystrophin-deficient mice.
od: Kevin J Sonnemann, i wsp.
Wydane: (2009-05-01)

Alternative utrophin mRNAs contribute to phenotypic differences between dystrophin-deficient mice and Duchenne muscular dystrophy
od: Perkins, K, i wsp.
Wydane: (2018)

The utrophin and dystrophin genes share similarities in genomic structure.
od: Pearce, M, i wsp.
Wydane: (1993)

Rescu of severely affected dystrophin/utrophin deficient mice by morpholino-oligomer mediated exon skipping
od: Goyenvalle, A, i wsp.
Wydane: (2010)

Heregulin-induced epigenetic regulation of the utrophin-A promoter.
od: Basu, U, i wsp.
Wydane: (2007)

Second-generation compound for the modulation of utrophin in the therapy of DMD
od: Guiraud, S, i wsp.
Wydane: (2015)

Utrophin influences mitochondrial pathology and oxidative stress in dystrophic muscle
od: Kennedy, T, i wsp.
Wydane: (2017)

A- and B-utrophin have different expression patterns and are differentially up-regulated in mdx muscle.
od: Weir, A, i wsp.
Wydane: (2002)

Non-toxic ubiquitous overexpression of utrophin in the mdx mouse.
od: Fisher, R, i wsp.
Wydane: (2000)

Micro-utrophin improves cardiac and skeletal muscle function of severely affected D2/mdx mice
od: Kennedy, T, i wsp.
Wydane: (2018)

Identification of serum protein biomarkers for utrophin based DMD therapy.
od: Guiraud, S, i wsp.
Wydane: (2017)

The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
od: Guiraud, S, i wsp.
Wydane: (2019)

Utrophin upregulation in DMD therapy: current status and new tools for the future
od: Fairclough, R, i wsp.
Wydane: (2011)

Prevention of dystrophic pathology in severely affected dystrophin/utrophin-deficient mice by morpholino-oligomer-mediated exon-skipping.
od: Goyenvalle, A, i wsp.
Wydane: (2010)

A quantitative study of bioenergetics in skeletal muscle lacking utrophin and dystrophin.
od: Cole, M, i wsp.
Wydane: (2002)

Non-toxic ubiquitous over-expression of utrophin in the mdx mouse.
od: Fisher, R, i wsp.
Wydane: (2001)

Ets, Ap-1 and GATA factor families regulate the utrophin B promoter: potential regulatory mechanisms for endothelial-specific expression.
od: Perkins, K, i wsp.
Wydane: (2003)

Utrophin in therapy of Duchenne muscular distrophy
od: Fisher, R
Wydane: (2001)

Metabolic profiles of dystrophin and utrophin expression in mouse models of Duchenne muscular dystrophy.
od: Griffin, J, i wsp.
Wydane: (2002)

The role of basal and myogenic factors in the transcriptional activation of utrophin promoter A: implications for therapeutic up-regulation in Duchenne muscular dystrophy.
od: Perkins, K, i wsp.
Wydane: (2001)